Advertisement
Advertisement
Trending on Dermatology Times
1
Insights from the Multinational RWEAL Study on CHE Etiology, Severity, and Real-World Management
2
French Early Access Data on Dupilumab in Pediatric Atopic Dermatitis
3
Comparative Analysis Positions Zasocitinib Among Next-Generation TYK2 Inhibitors
4
Journal Digest: January 14, 2026
5
